The table below shows Cogent Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$75.36M
$68.99M
$62.20M
$63.03M
$63.61M
$54.29M
SG&A
COGT annual revenue (10-K history)
Cogent Biosciences, Inc. reported annual revenue of $7.87M for fiscal year 2020. That is down 65.0% from $22.50M in fiscal 2019. Figures come from the company's audited annual reports as filed with the SEC.